Market Overview

UPDATE: Morgan Stanley Reiterates on Walgreen Company on Possible Re-Domiciling

Related WAG
Top 4 NYSE Stocks In The Drug Stores Industry With The Highest ROE
Walgreen Co. Or CVS Caremark: Which Would You Rather?
Cavuto: Call for Consistent Press Standards (Fox Business)

In a report published Tuesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $75.00 price target.

In the report, Morgan Stanley noted, “Strategically, re-domiciling could mean increased involvement from Pessina & AB. In a European structure, Stefano Pessina would likely be Executive Director, a role that typically encompasses setting company strategic direction. This differs from a US structure, where as a board member or potentially Chairman, Pessina & the board would approve the CEO's strategy.”

Walgreen Company closed on Monday at $65.67.

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Reiteration Analyst Ratings

 

Most Popular

Related Articles (WAG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters